Related Experiment Videos
Absorbed dose calculations for rapidly growing tumors
R W Howell1, V R Narra, D V Rao
1Department of Radiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark 07103.
Summary
Radiopharmaceutical cancer therapy is promising for small tumors, but rapid tumor growth during treatment can alter the delivered radiation dose. This study develops a method to calculate absorbed dose, accounting for tumor growth, crucial for effective cancer treatment.
Area of Science:
- Nuclear medicine
- Radiation oncology
- Cancer research
Background:
- Radiopharmaceuticals offer a promising avenue for treating small tumors and micrometastases.
- Rapid tumor growth during irradiation can significantly alter the total radiation dose delivered.
Purpose of the Study:
- To develop a formalism for calculating the average absorbed dose to rapidly growing tumors.
- To assess the impact of tumor growth on radiation dose from incorporated radionuclides.
Main Methods:
- Development of a mathematical formalism to calculate absorbed dose in growing tumors.
- Application of the formalism to an in vitro tumor model.
- In vivo study using human myeloma tumors.
Main Results:
- Tumor growth significantly affects the average absorbed dose delivered by incorporated radionuclides.
- The developed formalism accounts for changes in tumor mass during irradiation.
Conclusions:
- Accounting for tumor growth is essential for accurate dose calculations in radiopharmaceutical cancer therapy.
- This approach can aid in establishing critical dose-response relationships for improved treatment efficacy.